Suppr超能文献

免疫治疗新型冠状病毒感染的方法(综述)。

Immunological Approaches to the Treatment of New Coronavirus Infection (Review).

机构信息

Associate Professor, Department of Propedeutics of Internal Diseases; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

Assistant, Department of Propedeutics of Internal Diseases; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

出版信息

Sovrem Tekhnologii Med. 2021;13(3):81-99. doi: 10.17691/stm2021.13.3.09. Epub 2021 Jun 28.

Abstract

The pandemic of the new coronavirus infection (COVID-19) caused by the SARS-CoV-2 virus has spread all over the world. The large amount of information that appears every day requires comprehension and systematization. The immunological aspects of the virus-host interaction are the core issues in the effective treatment and prevention of COVID-19' development. The review analyzes the known pathways of the viral invasion and evasion, the mechanisms of the cytokine storm, endothelial damage, and hypercoagulability associated with SARS-CoV-2 infection. Clinical data from previous SARS and MERS epidemics is discussed here. We also address the therapeutic approaches based on the basic knowledge of immune response and the blood cells' immune functions, as well as the ways to reduce their hyperactivation. The use of interferon therapy, anti-inflammatory therapy, anti-cytokine therapy, neutralizing antibodies, convalescent plasma, and mesenchymal stem cells, as well as prophylactic vaccines, is discussed.

摘要

由 SARS-CoV-2 病毒引起的新型冠状病毒感染(COVID-19)大流行已在全球范围内蔓延。每天出现的大量信息需要理解和系统化。病毒-宿主相互作用的免疫学方面是有效治疗和预防 COVID-19 发展的核心问题。该综述分析了已知的病毒入侵和逃逸途径、细胞因子风暴、内皮损伤和与 SARS-CoV-2 感染相关的高凝机制。本文还讨论了基于免疫反应基础知识和血细胞免疫功能的治疗方法,以及降低其过度激活的方法。讨论了干扰素治疗、抗炎治疗、抗细胞因子治疗、中和抗体、恢复期血浆和间充质干细胞以及预防性疫苗的使用。

相似文献

1
Immunological Approaches to the Treatment of New Coronavirus Infection (Review).
Sovrem Tekhnologii Med. 2021;13(3):81-99. doi: 10.17691/stm2021.13.3.09. Epub 2021 Jun 28.
2
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
3
Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
Annu Rev Microbiol. 2021 Oct 8;75:19-47. doi: 10.1146/annurev-micro-110520-023212. Epub 2021 Jan 25.
4
Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic.
Eur J Pharmacol. 2021 Jan 5;890:173643. doi: 10.1016/j.ejphar.2020.173643. Epub 2020 Oct 13.
5
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
Scand J Immunol. 2021 Apr;93(4):e12998. doi: 10.1111/sji.12998. Epub 2020 Dec 3.
6
Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Drug Dev Res. 2021 Feb;82(1):12-26. doi: 10.1002/ddr.21720. Epub 2020 Jul 30.
8
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection.
J Biomed Sci. 2022 Jan 4;29(1):1. doi: 10.1186/s12929-021-00784-w.
10
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Microbiol Spectr. 2022 Feb 23;10(1):e0150421. doi: 10.1128/spectrum.01504-21. Epub 2022 Jan 5.

引用本文的文献

3
Immune-based therapeutic approaches in COVID-19.
Biomed Pharmacother. 2022 Jul;151:113107. doi: 10.1016/j.biopha.2022.113107. Epub 2022 May 16.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
3
Convalescent plasma to treat COVID-19: clinical experience and efficacy.
Aging (Albany NY). 2021 Mar 18;13(6):7758-7766. doi: 10.18632/aging.202795.
5
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
9
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验